LVMH-owned media group, Les Echos-Le Parisien, acquires Citadelles & Mazenod

LVMH-owned media group, Les Echos-Le Parisien, has recently made an undisclosed acquisition of the well-known publishing house, Citadelles & Mazenod. This strategic move serves to bolster LVMH’s art division within its media holdings. Citadelles & Mazenod will now be joining Les Echos-Le Parisien, the media subsidiary of LVMH, alongside other influential publications such as Connaissance des Arts magazine, Les Echos, Le Parisien, Investir, Boursier.com, and Radio Classique. This acquisition serves to solidify LVMH’s presence in the media, literary, and artistic landscape.

According to Pierre Louette, CEO of Les Echos-Le Parisien, this acquisition perfectly aligns with their core strategy of consolidating their strengths and fulfilling their mission of providing the best cultural and artistic content to a broad audience. Citadelles & Mazenod offers a diverse range of collections, both available online and in bookstores, including Les Fresques, Art and Nature, Art and Cities, and Illustrated Literature.

Having been established in 1936, Citadelles & Mazenod boasts an impressive annual consolidated revenue of approximately seven million euros. Thus, LVMH’s acquisition of this publishing house further demonstrates their commitment to expanding their presence in the publishing industry and extending their involvement in the cultural and artistic realms.

Useful links:
Citadelles & Mazenod Official Website (when applicable)
Les Echos Official Website (when applicable)

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Prev
Salvatore Ferragamo’s Retail Sales Reach Pre-Pandemic Levels

Salvatore Ferragamo’s Retail Sales Reach Pre-Pandemic Levels

Italian luxury brand Salvatore Ferragamo has announced that its retail sales in

Next
CFDA Announces 12 New Members and Introduces New Membership Tiers

CFDA Announces 12 New Members and Introduces New Membership Tiers

The Council of Fashion Designers of America (CFDA) has recently announced the

You May Also Like